These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Vlaskovska M, Hertting G, Knepel W. Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854 [Abstract] [Full Text] [Related]
3. Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers. Knepel W, Götz D. Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):149-55. PubMed ID: 3018594 [Abstract] [Full Text] [Related]
4. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei. Knepel W, Vlaskovska M, Meyer DK. Brain Res; 1985 Feb 04; 326(1):87-94. PubMed ID: 3155985 [Abstract] [Full Text] [Related]
5. Inhibition of prostaglandin synthesis and the release of vasopressin and oxytocin from the rat neurohypophysis: in vitro studies. Bojanowska E, Guzek JW. Exp Clin Endocrinol; 1991 Feb 04; 98(3):213-21. PubMed ID: 1778241 [Abstract] [Full Text] [Related]
6. The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro. Knepel W, Meyer DK. J Physiol; 1983 Aug 04; 341():507-15. PubMed ID: 6620188 [Abstract] [Full Text] [Related]
7. Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway. Vlaskovska M, Knepel W. Neuroendocrinology; 1984 Oct 04; 39(4):334-42. PubMed ID: 6092988 [Abstract] [Full Text] [Related]
8. Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypophysectomized rats. Knepel W, Przewlocki R, Nutto D, Herz A. Endocrinology; 1985 Jul 04; 117(1):292-9. PubMed ID: 3159565 [Abstract] [Full Text] [Related]
9. Centrally administered PGE2 inhibits gastric secretion in the rat by releasing vasopressin. Puurunen J, Leppäluoto J. Eur J Pharmacol; 1984 Sep 03; 104(1-2):145-50. PubMed ID: 6094207 [Abstract] [Full Text] [Related]
10. Role of inhibitory and stimulative effects of prostaglandins on vasopressin-stimulated osmotic water flow in the toad bladder. Marumo F. Jpn J Physiol; 1986 Sep 03; 36(5):935-44. PubMed ID: 3031349 [Abstract] [Full Text] [Related]
11. Absence of prostacyclin involvement in angiotensin-induced aldosterone secretion in rat adrenal cells. Campbell WB, Gomez-Sanchez CE. Endocrinology; 1985 Jul 03; 117(1):279-86. PubMed ID: 3924581 [Abstract] [Full Text] [Related]
12. Vasopressin release from rat medial basal hypothalamus in vitro after adrenalectomy or lesions of the paraventricular nuclei. Knepel W, Nutto D, Meyer DK, Vlaskovska M. Neurosci Lett; 1984 Aug 10; 48(3):321-6. PubMed ID: 6091001 [Abstract] [Full Text] [Related]
13. Naloxone increases vasopressin secretion from the neurointermediate lobe of the hypophysis of the rat: search for the endogenous agonist. Knepel W, Nutto D, Meyer DK. Life Sci; 1983 Aug 10; 33 Suppl 1():499-502. PubMed ID: 6664231 [Abstract] [Full Text] [Related]
14. Prostaglandin F2 alpha stimulates vasopressin and oxytocin release from isolated rat neurointermediate lobe. Bojanowska E, Guzek JW. Exp Clin Endocrinol; 1989 Aug 10; 94(3):375-82. PubMed ID: 2630314 [Abstract] [Full Text] [Related]
15. Potential role for prostaglandin F2 alpha, D2, E2 and thromboxane A2 in mediating the metabolic and hemodynamic actions of sympathetic nerves in perfused rat liver. Iwai M, Gardemann A, Püschel G, Jungermann K. Eur J Biochem; 1988 Jul 15; 175(1):45-50. PubMed ID: 3165341 [Abstract] [Full Text] [Related]
16. Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. Altin JG, Bygrave FL. Biochem J; 1988 Feb 01; 249(3):677-85. PubMed ID: 3128268 [Abstract] [Full Text] [Related]
17. Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland. Lamberts SW, Bons EG, Uitterlinden P, Hackeng WH. J Endocrinol; 1983 Mar 01; 96(3):395-400. PubMed ID: 6300274 [Abstract] [Full Text] [Related]
18. Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin. Hashimoto H, Noto T, Nakajima T. Prostaglandins Leukot Essent Fatty Acids; 1989 Apr 01; 36(1):9-14. PubMed ID: 2740415 [Abstract] [Full Text] [Related]
19. Effect of indomethacin on responses of sheep isolated coronary artery to arachidonic acid. Cornish EJ, Goldie RG, Krstew EV, Miller RC. Clin Exp Pharmacol Physiol; 1983 Apr 01; 10(2):171-5. PubMed ID: 6409479 [Abstract] [Full Text] [Related]
20. Inhibition by morphine and beta-endorphin of vasopressin release evoked by electrical stimulation of the rat medial basal hypothalamus in vitro. Knepel W, Reimann W. Brain Res; 1982 Apr 29; 238(2):484-8. PubMed ID: 6284302 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]